Concord Medical Services Stock Shares Outstanding

CCM Stock

USD 0.57 0.01 1.71%

Concord Medical Services fundamentals help investors to digest information that contributes to Concord Medical's financial success or failures. It also enables traders to predict the movement of Concord Stock. The fundamental analysis module provides a way to measure Concord Medical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Concord Medical stock.

Other Current Liab Total Assets

As of the 24th of April 2024, Common Stock Shares Outstanding is likely to drop to about 47 M.

This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Concord Medical Services Company Shares Outstanding Analysis

Concord Medical's Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.

Shares Outstanding

Public Shares

-

Repurchased

More About Shares Outstanding | All Equity Analysis

Current Concord Medical Shares Outstanding

43.42 M

Most of Concord Medical's fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Concord Medical Services is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Concord Shares Outstanding Driver Correlations

Understanding the fundamental principles of building solid financial models for Concord Medical is extremely important. It helps to project a fair market value of Concord Stock properly, considering its historical fundamentals such as Shares Outstanding. Since Concord Medical's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Concord Medical's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Concord Medical's interrelated accounts and indicators.

	Total Assets	Total Stockholder Equity	Long Term Debt	Good Will	Total Liab	Intangible Assets	Common Stock	Property Plant Equipment	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Net Receivables	Total Current Assets	Short Term Debt	Short Term Investments	Treasury Stock	Net Tangible Assets	Deferred Long Term Liab	Long Term Investments	Short Long Term Debt	Long Term Debt Total	Capital Surpluse	Cash And Equivalents	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		-0.53	0.76	0.55	0.82	0.65	0.75	0.74	0.65	0.77	-0.7	0.44	0.21	-0.09	0.3	-0.31	-0.63	-0.75	0.3	0.32	-0.3	0.72	0.67	0.12	-0.75	-0.35	-0.19
Total Stockholder Equity	-0.53		-0.9	-0.69	-0.81	-0.41	-0.03	-0.92	-0.88	-0.85	0.95	-0.4	0.42	0.59	-0.19	0.78	0.64	0.89	-0.27	-0.38	0.14	-0.92	-0.67	-0.05	0.9	0.71	0.6
Long Term Debt	0.76	-0.9		0.66	0.88	0.53	0.32	0.98	0.89	0.92	-0.94	0.4	-0.19	-0.5	0.15	-0.66	-0.72	-0.94	0.41	0.33	-0.32	0.98	0.74	0.0	-0.9	-0.6	-0.46
Good Will	0.55	-0.69	0.66		0.69	0.14	0.32	0.75	0.81	0.77	-0.83	0.83	-0.34	-0.43	0.4	-0.33	-0.21	-0.66	0.07	0.24	0.26	0.71	0.25	0.04	-0.73	-0.8	-0.71
Total Liab	0.82	-0.81	0.88	0.69		0.59	0.54	0.91	0.83	0.96	-0.9	0.53	-0.1	-0.19	0.57	-0.59	-0.76	-0.85	0.39	0.41	-0.27	0.9	0.81	0.04	-0.84	-0.69	-0.62
Intangible Assets	0.65	-0.41	0.53	0.14	0.59		0.39	0.47	0.3	0.43	-0.42	0.01	0.33	0.02	0.07	-0.41	-0.82	-0.5	0.25	0.37	-0.44	0.45	0.76	0.33	-0.56	0.07	0.05
Common Stock	0.75	-0.03	0.32	0.32	0.54	0.39		0.35	0.25	0.46	-0.29	0.23	0.32	0.28	0.47	0.2	-0.38	-0.35	0.19	0.11	-0.27	0.33	0.42	0.02	-0.31	-0.22	-0.17
Property Plant Equipment	0.74	-0.92	0.98	0.75	0.91	0.47	0.35		0.91	0.95	-0.97	0.45	-0.33	-0.51	0.26	-0.66	-0.7	-0.94	0.37	0.32	-0.24	1.0	0.73	0.02	-0.94	-0.73	-0.61
Current Deferred Revenue	0.65	-0.88	0.89	0.81	0.83	0.3	0.25	0.91		0.87	-0.94	0.59	-0.31	-0.41	0.27	-0.59	-0.5	-0.86	0.2	0.42	-0.04	0.92	0.54	0.17	-0.86	-0.71	-0.65
Net Debt	0.77	-0.85	0.92	0.77	0.96	0.43	0.46	0.95	0.87		-0.94	0.6	-0.19	-0.37	0.49	-0.61	-0.66	-0.88	0.4	0.33	-0.2	0.94	0.71	-0.1	-0.83	-0.78	-0.64
Retained Earnings	-0.7	0.95	-0.94	-0.83	-0.9	-0.42	-0.29	-0.97	-0.94	-0.94		-0.55	0.33	0.51	-0.3	0.64	0.62	0.92	-0.29	-0.38	0.11	-0.96	-0.66	-0.04	0.93	0.77	0.65
Accounts Payable	0.44	-0.4	0.4	0.83	0.53	0.01	0.23	0.45	0.59	0.6	-0.55		-0.03	-0.11	0.56	-0.19	0.03	-0.37	0.01	0.19	0.39	0.42	0.01	-0.06	-0.41	-0.6	-0.52
Net Receivables	0.21	0.42	-0.19	-0.34	-0.1	0.33	0.32	-0.33	-0.31	-0.19	0.33	-0.03		0.63	-0.02	0.38	0.02	0.18	-0.12	0.12	-0.24	-0.32	-0.06	-0.03	0.31	0.58	0.61
Total Current Assets	-0.09	0.59	-0.5	-0.43	-0.19	0.02	0.28	-0.51	-0.41	-0.37	0.51	-0.11	0.63		0.36	0.55	0.23	0.41	-0.11	-0.1	-0.21	-0.5	-0.19	0.25	0.49	0.41	0.22
Short Term Debt	0.3	-0.19	0.15	0.4	0.57	0.07	0.47	0.26	0.27	0.49	-0.3	0.56	-0.02	0.36		-0.11	-0.22	-0.17	0.19	0.18	0.09	0.25	0.31	-0.12	-0.15	-0.6	-0.63
Short Term Investments	-0.31	0.78	-0.66	-0.33	-0.59	-0.41	0.2	-0.66	-0.59	-0.61	0.64	-0.19	0.38	0.55	-0.11		0.66	0.57	-0.33	-0.5	0.03	-0.66	-0.65	0.05	0.61	0.42	0.34
Treasury Stock	-0.63	0.64	-0.72	-0.21	-0.76	-0.82	-0.38	-0.7	-0.5	-0.66	0.62	0.03	0.02	0.23	-0.22	0.66		0.64	-0.43	-0.48	0.39	-0.7	-0.98	-0.08	0.66	0.27	0.23
Net Tangible Assets	-0.75	0.89	-0.94	-0.66	-0.85	-0.5	-0.35	-0.94	-0.86	-0.88	0.92	-0.37	0.18	0.41	-0.17	0.57	0.64		-0.2	-0.3	0.38	-0.94	-0.67	-0.05	0.95	0.62	0.48
Deferred Long Term Liab	0.3	-0.27	0.41	0.07	0.39	0.25	0.19	0.37	0.2	0.4	-0.29	0.01	-0.12	-0.11	0.19	-0.33	-0.43	-0.2		-0.17	-0.39	0.4	0.53	-0.19	-0.19	-0.24	-0.11
Long Term Investments	0.32	-0.38	0.33	0.24	0.41	0.37	0.11	0.32	0.42	0.33	-0.38	0.19	0.12	-0.1	0.18	-0.5	-0.48	-0.3	-0.17		0.3	0.32	0.43	0.01	-0.33	-0.14	-0.13
Short Long Term Debt	-0.3	0.14	-0.32	0.26	-0.27	-0.44	-0.27	-0.24	-0.04	-0.2	0.11	0.39	-0.24	-0.21	0.09	0.03	0.39	0.38	-0.39	0.3		-0.27	-0.41	-0.18	0.22	-0.15	-0.09
Long Term Debt Total	0.72	-0.92	0.98	0.71	0.9	0.45	0.33	1.0	0.92	0.94	-0.96	0.42	-0.32	-0.5	0.25	-0.66	-0.7	-0.94	0.4	0.32	-0.27		0.74	0.02	-0.92	-0.72	-0.6
Capital Surpluse	0.67	-0.67	0.74	0.25	0.81	0.76	0.42	0.73	0.54	0.71	-0.66	0.01	-0.06	-0.19	0.31	-0.65	-0.98	-0.67	0.53	0.43	-0.41	0.74		0.05	-0.67	-0.37	-0.28
Cash And Equivalents	0.12	-0.05	0.0	0.04	0.04	0.33	0.02	0.02	0.17	-0.1	-0.04	-0.06	-0.03	0.25	-0.12	0.05	-0.08	-0.05	-0.19	0.01	-0.18	0.02	0.05		-0.19	0.26	-0.08
Net Invested Capital	-0.75	0.9	-0.9	-0.73	-0.84	-0.56	-0.31	-0.94	-0.86	-0.83	0.93	-0.41	0.31	0.49	-0.15	0.61	0.66	0.95	-0.19	-0.33	0.22	-0.92	-0.67	-0.19		0.63	0.52
Net Working Capital	-0.35	0.71	-0.6	-0.8	-0.69	0.07	-0.22	-0.73	-0.71	-0.78	0.77	-0.6	0.58	0.41	-0.6	0.42	0.27	0.62	-0.24	-0.14	-0.15	-0.72	-0.37	0.26	0.63		0.87
Capital Stock	-0.19	0.6	-0.46	-0.71	-0.62	0.05	-0.17	-0.61	-0.65	-0.64	0.65	-0.52	0.61	0.22	-0.63	0.34	0.23	0.48	-0.11	-0.13	-0.09	-0.6	-0.28	-0.08	0.52	0.87

Click cells to compare fundamentals

Concord Shares Outstanding Historical Pattern

Today, most investors in Concord Medical Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Concord Medical's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's shares outstanding growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Concord Medical shares outstanding as a starting point in their analysis.

Concord Medical Shares Outstanding

Timeline

Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.

Competition

Predict Concord Medical

Common Stock Shares Outstanding Over Time

Concord Common Stock Shares Outstanding

Common Stock Shares Outstanding

47.01 Million

At this time, Concord Medical's Common Stock Shares Outstanding is very stable compared to the past year.

Based on the latest financial disclosure, Concord Medical Services has 43.42 M of shares currently outstending. This is 75.95% lower than that of the Health Care Providers & Services sector and significantly higher than that of the Health Care industry. The shares outstanding for all United States stocks is 92.41% higher than that of the company.

Concord Shares Outstanding Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Concord Medical's direct or indirect competition against its Shares Outstanding to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Concord Medical could also be used in its relative valuation, which is a method of valuing Concord Medical by comparing valuation metrics of similar companies.

Concord Medical is currently under evaluation in shares outstanding category among related companies.

Concord Medical Current Valuation Drivers

We derive many important indicators used in calculating different scores of Concord Medical from analyzing Concord Medical's financial statements. These drivers represent accounts that assess Concord Medical's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Concord Medical's important valuation drivers and their relationship over time.

	2019	2020	2021	2022	2023	2024 (projected)
Market Cap	806.0M	781.1M	556.7M	494.1M	341.0M	324.0M
Enterprise Value	2.6B	2.8B	3.1B	3.6B	3.5B	3.7B

Concord Fundamentals

	Return On Equity	-0.28
	Return On Asset	-0.048
	Profit Margin	(0.55) %
	Operating Margin	(0.98) %
	Current Valuation	7.18 B
	Shares Outstanding	43.42 M
	Shares Owned By Insiders	17.99 %
	Shares Owned By Institutions	0.10 %
	Number Of Shares Shorted	14.54 K
	Price To Earning	(3.90) X
	Price To Book	3.00 X
	Price To Sales	0.04 X
	Revenue	537.4 M
	Gross Profit	(152.41 M)
	EBITDA	(344.16 M)
	Net Income	(297.66 M)
	Cash And Equivalents	157.39 M
	Cash Per Share	1.72 X
	Total Debt	3.25 B
	Debt To Equity	1.25 %
	Current Ratio	0.71 X
	Book Value Per Share	(48.87) X
	Cash Flow From Operations	(276.47 M)
	Short Ratio	0.64 X
	Earnings Per Share	(0.94) X
	Target Price	1.2
	Number Of Employees	727
	Beta	-0.17
	Market Capitalization	25.18 M
	Total Asset	6.05 B
	Retained Earnings	(4.06 B)
	Working Capital	(1.33 B)
	Current Asset	1.51 B
	Current Liabilities	1.51 B
	Net Asset	6.05 B

About Concord Medical Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Concord Medical Services's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Concord Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Concord Medical Services based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Please read more on our fundamental analysis page.

Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Concord Medical in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Concord Medical's short interest history, or implied volatility extrapolated from Concord Medical options trading.

When determining whether Concord Medical Services is a strong investment it is important to analyze Concord Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Concord Medical's future performance. For an informed investment choice regarding Concord Stock, refer to the following important reports:

How To Invest In Concord

Details

Is Concord Stock a good investment?

Details

What is Concord Medical's Net Worth?

Details

Largest Health Care Providers & Services Companies

View

Largest Health Care Equipment & Services Companies

View

Check out Concord Medical Piotroski F Score and Concord Medical Altman Z Score analysis.

Note that the Concord Medical Services information on this page should be used as a complementary analysis to other Concord Medical's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.

Complementary Tools for Concord Stock analysis

When running Concord Medical's price analysis, check to measure Concord Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Concord Medical is operating at the current time. Most of Concord Medical's value examination focuses on studying past and present price action to predict the probability of Concord Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Concord Medical's price. Additionally, you may evaluate how the addition of Concord Medical to your portfolios can decrease your overall portfolio volatility.

	Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings
	Equity Valuation Check real value of public entities based on technical and fundamental data
	Analyst Advice Analyst recommendations and target price estimates broken down by several categories
	Money Managers Screen money managers from public funds and ETFs managed around the world
	Stocks Directory Find actively traded stocks across global markets
	Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios

Is Concord Medical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Concord Medical. If investors know Concord will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Concord Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(0.94)

Revenue Per Share

12.302

Quarterly Revenue Growth

(0.23)

Return On Assets

(0.05)

Return On Equity

(0.28)

The market value of Concord Medical Services is measured differently than its book value, which is the value of Concord that is recorded on the company's balance sheet. Investors also form their own opinion of Concord Medical's value that differs from its market value or its book value, called intrinsic value, which is Concord Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Concord Medical's market value can be influenced by many factors that don't directly affect Concord Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Concord Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Concord Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Concord Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Concord Medical Services Stock Shares Outstanding

Concord Medical Services Company Shares Outstanding Analysis

Shares Outstanding

Public Shares

-

Repurchased

Current Concord Medical Shares Outstanding

Concord Shares Outstanding Driver Correlations

Concord Shares Outstanding Historical Pattern

Concord Common Stock Shares Outstanding

Common Stock Shares Outstanding

47.01 Million

Concord Shares Outstanding Peer Comparison

Concord Medical Current Valuation Drivers

Concord Fundamentals

About Concord Medical Fundamental Analysis

Complementary Tools for Concord Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY